(B) Validation of JAM-C down-regulation in HUVECs following siRNA delivery by qPCR. 1 silenced > Albaspidin AA 75% from the huJAM-C mRNA in HUVECs after transfection and was employed for all monocyte Albaspidin AA coculture tests. Bars represent imply standard deviation (SD) (3 experiments, each condition in triplicate). P values were calculated compared to control siRNA (* = P<0.05; ** = P<0.01). (C) Validation of JAM-C down-regulation on HUVECs by circulation cytometry. JAM-C expression on HUVECs was reduced after transfection with siRNA1 (pink) and 2 (blue), compared to JAM-C expression on non-transfected HUVECs (green). Expression of JAM-C on HUVECs transfected with control siRNA (blue) and non-transfected HUVECs remained comparable. An isotype control was included in all experiments (black). Histograms are representative of at least 2 experiments. (D) Overexpression of recombinant JAM-C does not impact distribution of other Rabbit polyclonal to ALDH3B2 junctional proteins. Localization of the junctional proteins VE-Cadherin. PECAM-1. Occludin-1, Claudin-5, AF6 and ZO-1 were examined using confocal microscopy. No differences were observed between cells transfected with the control EGFP (marked as -) and JAM-C-EGFP constructs (marked as +). Images are representative of at least 4 impartial experiments (N = 4). All antibody isotype controls included for immunofluorescence showed no staining (data not shown).(TIF) pone.0159679.s002.tif (9.5M) GUID:?E38105AF-A588-462D-B0D6-A1D2B296321F S2 Fig: Functional expression of JAM-C-EGFP on cultured HUVECs after stimulation. (A) Cultured HUVEC monolayers were stimulated with TNF-alpha and fixed at set time-points of 0 (unstimulated), 1- and 4-hrs. Human HUVECs were stained for human JAM-C using antibody 225.3 or an isotype control. JAM-C distribution remained unchanged throughout the 4-hr time-course with JAM-C remaining mostly in the junctions. The isotype control antibody showed no staining (data not shown). (B) Cultured HUVEC monolayers were transfected with JAM-C-EGFP lentivirus and stimulated with TNF-alpha at 0 (unstimulated), 1- and 4-hrs. Distribution of JAM-C-EGFP was much like endogenous JAM-C and localized to intercellular junctions but also showed accumulation intracellularly. (C) Analysis by circulation cytometry established total JAM-C expression in 73C76% of HUVECs transfected with JAM-C-EGFP and this increased in a linear fashion when compared to total JAM-C. Identical profiles were seen at 0-, 1- and 4-hrs after activation with TNF-alpha. (D) Increased total JAM-C expression using the JAM-C-EGFP construct (squares) was typically ~2-occasions higher than normal endogenous JAM-C expression (circles). (E) Comparison of JAM-C expression to the starting level of expression (MFI) in the endogenous (circles), total (squares) and JAM-C-EGFP populations (triangles) confirmed expression levels in each populace were stable and remained unchanged up to 24-hrs. (F) An example set of circulation cytometry profiles illustrating how total JAM-C expression increases with LV-JAM-C-EGFP weight (G) Titration of LV-JAM-C-EGFP on cultured HUVECs. Circulation cytometry studies indicated lentivirus JAM-C-EGFP preparation on cultured HUVECs stimulated with TNF-alpha increased total surface JAM-C expression in a dose-dependent manner. Titrations tested in this experiment were 1:100 (white circles), 1:500 (grey circles), 1:1000 (white triangle), 1:2000 (grey triangle), 1:5000 (white square) and a no computer virus control (grey square). Profiles of JAM-C expression remained constant at all concentrations up to 24-hrs for each concentration. (H) The MFI of total JAM-C expression increased in a linear fashion with LV weight. Dilution rates of 1/1000 and 1/100 were used to generate HUVECs with 1.8 (JAM-C-1.8x) and 6.6 fold increase (JAM-C-6.6x) above homeostatic JAM-C levels. (I) Increasing JAM-C expression had no effect on VE-cadherin expression. While JAM-C expression was increased on HUVECs, VE-cadherin remained unaffected. (J) VE-cadherin remained similarly unaffected on HUVECs after 4-hrs activation with TNF-alpha (conditions used in circulation assay). Data shown is representative of two impartial experiments (N = 2).(TIF) pone.0159679.s003.tif (9.5M) GUID:?30745845-F94B-4970-AC4F-654EC6077C0B S3 Fig: Single cell-tracking of individual monocytes on activated HUVECs under circulation. (A, B) Images are for two example monocytes (A and B) and contain representative cell tracking paths, plus a corresponding summary table detailing cell position and velocity analysis. The Capture point from circulation, and cell position is represented by circles denoting the time (mins) and XY position. Circles with a black or reddish border denote a monocyte in the luminal and abluminal compartment respectively. The track direction is represented by green and reddish songs for monocyte-A and -B respectively. An early timepoint of 15-mins was selected for the images in order to illustrate the tracking paths associated with each monocyte in different compartments. The extended track of Monocyte-A andCB can be observed as Monocyte-2 and -3 respectively in S2 Movie. The XY pixel coordinates and time for each individual monocyte were summarised in furniture, allowing luminal and abluminal velocities Albaspidin AA to be recorded (data units marked in.